Optimized tandem BCMA-specific CAR T cells designed to minimize tonic signaling and off-target toxicity
Authors:
- Xu WangXWXu Wang
- Peirong HuPHPeirong Hu
- Brittany L. SteimleBSBrittany L. Steimle
- Michael WagnerMWMichael Wagner
- Patricia S. LanganPLPatricia S. Langan
- Kun LuoKLKun Luo
- Saule T. NurmukhambetovaSNSaule T. Nurmukhambetova
- Genqing LiangGLGenqing Liang
- Ngoc Quang TranNTNgoc Quang Tran
- Wei XiongWXWei Xiong
- Dina SchneiderDSDina Schneider
- Rimas J. OrentasRORimas J. Orentas
Open Access
- 27 July 2026
- journal article
- Published by Elsevier in Blood Immunology & Cellular Therapy
- Vol. 2 (4)
Abstract
No abstract availableFunding Information
- Miltenyi Biotec
This publication has 30 references indexed in Scilit:
- Immunotherapy-related cognitive impairment after CAR T cell therapy in miceCell, 2025
- Endogenous bystander killing mechanisms enhance the activity of novel FAP‐specific CAR‐T cells against glioblastomaClinical & Translational Immunology, 2024
- PEP-Patch: Electrostatics in Protein–Protein Recognition, Specificity, and Antibody DevelopabilityJournal of Chemical Information and Modeling, 2023
- Microglia in neurodegenerative diseases: mechanism and potential therapeutic targetsSignal Transduction and Targeted Therapy, 2023
- Microglial depletion exacerbates motor impairment and dopaminergic neuron loss in a 6-OHDA model of Parkinson's diseaseJournal of Neuroimmunology, 2023
- Neurotoxicity Associated with CD19-Targeted CAR-T Cell TherapiesCNS Drugs, 2018
- Tonic Signals: Why Do Lymphocytes Bother?Trends in Immunology, 2017
- Improvements to the APBS biomolecular solvation software suiteProtein Science, 2017
- Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-DependentCell Reports, 2017
- 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptorsNature Medicine, 2015